Articaine Injection, Solution
Product Images NDC 66975-418

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Articaine (NDC 66975-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Benco Dental, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66975 418 51

Packaging label for Articaine HCl 4% (40 mg/mL) and Epinephrine 1:200,000 Injection, a submucosal injection solution. The label shows active ingredients Articaine Hydrochloride and Epinephrine Tartrate with concentrations. It indicates 50 single-dose cartridges of 1.7 mL each. Labeler is Benco Dental and manufacturer is Novocol Pharmaceuticals of Canada. The label includes storage instructions and barcodes.*

FDA Label Image

Articaine HCl

Chemical structure of Articaine Hydrochloride, showing its molecular components including a thiophene ring and hydrochloride moiety, consistent with the active ingredient Articaine Hydrochloride and Epinephrine in the product.*

FDA Label Image

Epinephrine Bitartrate

Chemical structure of the active ingredients Articaine Hydrochloride and Epinephrine as depicted in the image. The diagram shows the molecular arrangements relevant to the drug ARTICAINE injection solution by Benco Dental.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.